Simulect 10 mg powder and solvent for solution for injection or infusion

Licence status
Authorised: 07/03/2003
Active substances
Basiliximab
Dosage Form
Powder and solvent for solution for injection/infusion
Licence number
EU/1/98/084/002
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
L04AC Interleukin inhibitors, L04AC02 basiliximab
Legal supply status
Product subject to Restricted Prescription (C)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
07/03/2003